Development of small molecule MSI1/2 inhibitors to treat memory disorders

Research unit

INNOSUISSE

Project number

123.289 IP-LS

Project title

Development of small molecule MSI1/2 inhibitors to treat memory disorders

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	Accelerated forgetting in diseases like Alzheimer?s lacks effective treatments. We identified Musashi1/2 (MSI) as key to memory loss and developed MSI inhibitors now entering lead optimization. We aim to further develop this series to improve efficacy, IP position and drug-like properties.